TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation
Article in Cancer Biology & Therapy (March 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
TOP2A deficiency leads to human recurrent spontaneous abortion and growth retardation of mouse pre-implantation embryos
Article in Molecular Medicine (December 2022)
TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.
Article in American Journal of Cancer Research (September 2022)